London Clubs Stock Quote LCI - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

Bid

Ask

Volume

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Previous Close

Open

Last Trade

Last Trade Time

Average Volume (3m)

Financial Volume

VWAP

Update on Eagle Pharma's Ryanodex - Analyst Blog

Eagle Pharmaceuticals, Inc. (EGRX), which went public last month, has as many as six candidates in its pipeline in addition to two approved products. The company, which raised more than $50...

Bull of the Day: Lannett (LCI) - Bull of the Day

Lannett Company, Inc. (LCI) is cashing in on generic drugs as it recently reported record sales and gross margins. This Zacks Rank #1 (Strong Buy) is expected to grow earnings by 329% in fiscal...

Enanta (ENTA) Worth Watching: Stock Rises 13.4% - Tale of the Tape

Enanta Pharmaceuticals, Inc. (ENTA) was a big mover last session with its shares rising over 13% on the day. The move came on solid volume too with far more shares changing hands than in a normal...

Update on GALT's GR-MD-02 - Analyst Blog

Galectin Therapeutics Inc.’s (GALT) carbohydrate-based galectin inhibitor GR-MD-02 is currently in phase I development for the treatment of nonalcoholic steatohepatitis (NASH) with...

Avanir Gives Preliminary Q1 Update - Analyst Blog

Avanir Pharmaceuticals, Inc. (AVNR) announced preliminary results for the first quarter of fiscal 2014 (year ending in Sep 2014) with gross revenues of roughly $34.6 million ahead of the...

Aratana Acquires Okapi - Analyst Blog

In a bid to strengthen its position in pet therapeutics, Aratana Therapeutics, Inc. (PETX) recently announced that it has acquired Belgium-based Okapi Sciences NV. Okapi owns a proprietary pet...

RedHill Biopharma Sells ADS Again - Analyst Blog

RedHill Biopharma Ltd. (RDHL) currently does not have any approved product in its portfolio and is making efforts to invest in the development of its late-stage candidates. RedHill Biopharma...

Gentium Upgraded to Strong Buy - Analyst Blog

On Jan 2, 2014, Zacks Investment Research upgraded Gentium (GENT) to a Zacks Rank #1 (Strong Buy). Why the Upgrade? Shares of Gentium, an Italy-based biopharma company, have been on an...

Glaxo Divests Certain Assets - Analyst Blog

GlaxoSmithKline (GSK) announced that it has completed the divestment of its thrombosis brands, Arixtra and Fraxiparine and nutritional drinks brands Lucozade and Ribena. We remind investors...

Galectin Therapeutics (GALT) in Focus: Stock Moves Up 13.2% - Tale of the Tape

Galectin Therapeutics, Inc. (GALT) was a big mover last session, as the company saw its shares rise over 13% on the day. The move came on solid volume too with far more shares changing hands than...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
DPSTDirexion Daily Regional Banks Bull 3X Shares	$ 106.65 (15.20%)	2.98M
URAADirexion Daily Uranium Industry Bull 2x Shares	$ 20.05 (15.06%)	12.61k
ADRT.UAult Disruptive Technologies Corporation	$ 14.00 (14.75%)	121
DXFDunxin Financial Holdings Ltd	$ 0.1567 (14.13%)	664.03k
URAXDefiance Daily Target 2x Long Uranium ETF	$ 13.1493 (14.04%)	49.18k
CLDICalidi Biotherapeutics Inc	$ 1.125 (-21.88%)	526.05k
AMSAmerican Shared Hospital Services	$ 3.1515 (-12.46%)	567.31k
UVIX2x Long VIX Futures ETF	$ 4.345 (-11.51%)	17.6M
AIRIAir Industries Group	$ 6.35 (-11.44%)	1.86M
ETHDProshares Ultrashort Ether ETF	$ 56.09 (-11.21%)	46.71k
SOXLDirexion Daily Semiconductor Bull 3X Shares	$ 40.40 (7.70%)	87.13M
SOXSDirexion Daily Semiconductor Bear 3X Shares New	$ 21.52 (-7.76%)	81.77M
SPYSPDR S&P 500	$ 562.13 (1.06%)	49.54M
SPXSDirexion Daily S&P 500 Bear 3X Shares New	$ 7.15 (-3.12%)	44.27M
VHAIVocodia Holdings Corp	$ 0.0598 (-7.29%)	41.44M